Geron Corp. (GERN)
1.52
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Geron Price to Book Value : 4.467 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 4.467 |
| August 20, 2026 | 4.555 |
| August 19, 2026 | 4.673 |
| August 18, 2026 | 4.496 |
| August 17, 2026 | 4.496 |
| August 14, 2026 | 4.320 |
| August 13, 2026 | 4.511 |
| August 12, 2026 | 4.614 |
| August 11, 2026 | 4.790 |
| August 10, 2026 | 4.350 |
| August 07, 2026 | 4.350 |
| August 06, 2026 | 4.614 |
| August 05, 2026 | 4.790 |
| August 04, 2026 | 3.938 |
| August 03, 2026 | 3.762 |
| July 31, 2026 | 3.791 |
| July 30, 2026 | 3.938 |
| July 29, 2026 | 4.114 |
| July 28, 2026 | 4.261 |
| July 27, 2026 | 4.350 |
| July 24, 2026 | 4.173 |
| July 23, 2026 | 4.261 |
| July 22, 2026 | 4.144 |
| July 21, 2026 | 4.232 |
| July 20, 2026 | 4.232 |
| Date | Value |
|---|---|
| July 17, 2026 | 4.232 |
| July 16, 2026 | 4.173 |
| July 15, 2026 | 4.173 |
| July 14, 2026 | 4.056 |
| July 13, 2026 | 4.173 |
| July 10, 2026 | 4.408 |
| July 09, 2026 | 4.585 |
| July 08, 2026 | 4.585 |
| July 07, 2026 | 4.379 |
| July 06, 2026 | 4.232 |
| July 02, 2026 | 3.997 |
| July 01, 2026 | 3.732 |
| June 30, 2026 | 3.762 |
| June 29, 2026 | 3.637 |
| June 26, 2026 | 3.693 |
| June 25, 2026 | 3.833 |
| June 24, 2026 | 3.875 |
| June 23, 2026 | 3.777 |
| June 22, 2026 | 3.749 |
| June 18, 2026 | 3.526 |
| June 17, 2026 | 3.442 |
| June 16, 2026 | 3.302 |
| June 15, 2026 | 3.218 |
| June 12, 2026 | 3.218 |
| June 11, 2026 | 3.190 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Precigen, Inc. | 58.99 |
| Editas Medicine, Inc. | 4.375 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.53 |
| Anika Therapeutics, Inc. | 2.077 |
Price to Book Value Related Metrics
| PS Ratio | 4.968 |
| Price | 1.52 |
| Earnings Yield | -6.88% |
| Market Cap | 976.55M |